Clinical validity of NGS and innovation in clinical diagnosis
Clinical validity of NGS and innovation in clinical diagnosis
6-factor prognostic model for patients with advanced urothelial carcinoma
Comment: Urothelial cancer research from ASCO GU 2018
Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification
Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients
Radium-223 for bone predominant metastatic castration resistant prostate cancer
Latest in adjuvant therapy for renal cell carcinoma
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer
Detection and clinical significance of dense breast tissue
Challenges in cervical radiotherapy